Indivior loses battle over Suboxone generic
22-11-2018
Indivior settles addiction drug dispute with Par
16-05-2018
Indivior pledges to appeal generic Suboxone decision
26-03-2018
Kerrick / iStockphoto.com
Addiction treatment drug producer Indivior has obtained a temporary restraining order against Indian generic maker Dr Reddy’s, blocking the company from launching a generic version of Suboxone (buprenorphine and naloxone) Film.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Indivior, generics, Suboxone, Dr Reddy’s, patent infringement, opioid addiction, ANDA, FDA
